Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ï¿¥196,066.11, with a 24-hour trading volume of ï¿¥0. The asset's market cap is ï¿¥174.84T, after moving 0.86% in the last day.
Tokenized Eli Lilly And Co is trading at ï¿¥196,987.71, with a tokenized market cap of ï¿¥7.5B and a 24-hour trading volume of ï¿¥267.71M. The tokenized asset has moved -0.76% in the past 24 hours.